Sapa J - Search Results

1

Synthesis and Pharmacological Evaluation of Novel Silodosin-Based Arylsulfonamide Derivatives as α_1A/α_1D-Adrenergic Receptor Antagonist with Potential Uroselective Profile.

Canale V, Rak A, Kotańska M, Knutelska J, Siwek A, Bednarski M, Nowiński L, Zygmunt M, Koczurkiewicz P, Pękala E, Sapa J, Zajdel P. Canale V, et al. Among authors: sapa j. Molecules. 2018 Aug 29;23(9):2175. doi: 10.3390/molecules23092175. Molecules. 2018. PMID: 30158432 Free PMC article.

2

Search for new antiarrhythmic and hypotensive compounds. Synthesis, antiarrhythmic, antihypertensive, and alpha-adrenoceptor blocking activity of novel 1-[(2-hydroxy-3-amino)]-propylpyrrolidin-2-one derivatives.

Filipek B, Sapa J, Malawska B, Kulig K, Antkiewicz-Michaluk L. Filipek B, et al. Among authors: sapa j. Arch Pharm (Weinheim). 1997 Jul;330(7):225-31. doi: 10.1002/ardp.19973300707. Arch Pharm (Weinheim). 1997. PMID: 9311302

3

Synthesis and properties of 2-(4-substituted)butyl derivatives of some 2,3-dihydro-1,3-dioxo-1H-pyrrolo[3,4-c]pyridines.

Sladowska H, Szkatuła D, Filipek B, Maciag D, Sapa J, Zygmunt M. Sladowska H, et al. Among authors: sapa j. Pharmazie. 2001 Feb;56(2):133-8. Pharmazie. 2001. PMID: 11234340

4

Synthesis, antiarrhythmic, and antihypertensive effects of novel 1-substituted pyrrolidin-2-one and pyrrolidine derivatives with adrenolytic activity.

Malawska B, Kulig K, Filipek B, Sapa J, Maciag D, Zygmunt M, Antkiewicz-Michaluk L. Malawska B, et al. Among authors: sapa j. Eur J Med Chem. 2002 Mar;37(3):183-95. doi: 10.1016/s0223-5234(01)01321-6. Eur J Med Chem. 2002. PMID: 11900863

5

Synthesis, structure and antiarrhythmic properties evaluation of new basic derivatives of 5,5-diphenylhydantoin.

Kieć-Kononowicz K, Stadnicka K, Mitka A, Pekala E, Filipek B, Sapa J, Zygmunt M. Kieć-Kononowicz K, et al. Among authors: sapa j. Eur J Med Chem. 2003 Jun;38(6):555-66. doi: 10.1016/s0223-5234(03)00075-8. Eur J Med Chem. 2003. PMID: 12832127

6

Investigations on the synthesis and pharmacological properties of N-substituted derivatives of 4-alkoxy-6-methyl-1H-pyrrolo[3,4-c]pyridine-1,3(2H)-diones.

Sladowska H, Filipek B, Szkatuła D, Sapa J, Bednarski M, Ciołkowska M. Sladowska H, et al. Among authors: sapa j. Farmaco. 2005 Jan;60(1):53-9. doi: 10.1016/j.farmac.2004.08.011. Epub 2004 Dec 19. Farmaco. 2005. PMID: 15652370

7

Synthesis and pharmacological evaluation of pyrrolidin-2-one derivatives as antiarrhythmic, antihypertensive and alpha-adrenolytic agents.

Kulig K, Spieces C, Sapa J, Caspers C, Filipek B, Malawska B. Kulig K, et al. Among authors: sapa j. Pharmacol Rep. 2010 Jan-Feb;62(1):68-85. doi: 10.1016/s1734-1140(10)70244-9. Pharmacol Rep. 2010. PMID: 20360617 Free article.

8

Antiparkinsonian effects of novel adenosine A(2A) receptor antagonists.

Drabczyńska A, Zygmunt M, Sapa J, Filipek B, Müller CE, Kieć-Kononowicz K. Drabczyńska A, et al. Among authors: sapa j. Arch Pharm (Weinheim). 2011 Jan;344(1):20-7. doi: 10.1002/ardp.201000124. Epub 2010 Nov 18. Arch Pharm (Weinheim). 2011. PMID: 21213348

9

Antiarrhythmic and hypotensive activities of 1-[2-hydroxy-3-(4-phenyl-1-piperazinyl)propyl]-pyrrolidin-2-one (MG-1(R,S)) and its enantiomers.

Sapa J, Filipek B, Nowiński L. Sapa J, et al. Pharmacol Rep. 2011;63(2):455-63. doi: 10.1016/s1734-1140(11)70512-6. Pharmacol Rep. 2011. PMID: 21602601 Free article.

10

The possible mechanism of hypotensive activity of some pyrrolidin-2-one derivatives with antagonist properties at alpha1-adrenoceptors.

Sapa J, Kubacka M. Sapa J, et al. Eur J Pharmacol. 2011 Dec 30;673(1-3):40-8. doi: 10.1016/j.ejphar.2011.05.010. Epub 2011 May 18. Eur J Pharmacol. 2011. PMID: 21605554

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

108 results

Search Page